TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections

Sakiko Inamoto, Callie S. Kwartler, Andrea L. Lafont, Yao Yun Liang, Van Tran Fadulu, Senthil Duraisamy, Marcia Willing, Anthony Estrera, Hazim Safi, Mark C. Hannibal, John Carey, John Wiktorowicz, Filemon K. Tan, Xin Hua Feng, Hariyadarshi Pannu, Dianna M. Milewicz

    Research output: Contribution to journalArticle

    69 Citations (Scopus)

    Abstract

    AimsTransforming growth factor-β (TGF-β) signaling is critical for the differentiation of smooth muscle cells (SMCs) into quiescent cells expressing a full repertoire of contractile proteins. Heterozygous mutations in TGF-β receptor type II (TGFBR2) disrupt TGF-β signaling and lead to genetic conditions that predispose to thoracic aortic aneurysms and dissections (TAADs). The aim of this study is to determine the molecular mechanism by which TGFBR2 mutations cause TAADs.Methods and resultsUsing aortic SMCs explanted from patients with TGFBR2 mutations, we show decreased expression of SMC contractile proteins compared with controls. Exposure to TGF-β1 fails to increase expression of contractile genes in mutant SMCs, whereas control cells further increase expression of these genes. Analysis of fixed and frozen aortas from patients with TGFBR2 mutations confirms decreased in vivo expression of contractile proteins relative to unaffected aortas. Fibroblasts explanted from patients with TGFBR2 mutations fail to transform into mature myofibroblasts with TGF-β1 stimulation as assessed by expression of contractile proteins.ConclusionsThese data support the conclusion that heterozygous TGFBR2 mutations lead to decreased expression of SMC contractile protein in both SMCs and myofibroblasts. The failure of TGFBR2-mutant SMCs to fully express SMC contractile proteins predicts defective contractile function in these cells and aligns with a hypothesis that defective SMC contractile function contributes to the pathogenesis of TAAD.

    Original languageEnglish (US)
    Pages (from-to)520-529
    Number of pages10
    JournalCardiovascular Research
    Volume88
    Issue number3
    DOIs
    StatePublished - Dec 1 2010

    Fingerprint

    Thoracic Aortic Aneurysm
    Smooth Muscle Myocytes
    Dissection
    Contractile Proteins
    Phenotype
    Mutation
    Myofibroblasts
    Aorta
    Gene Expression
    Intercellular Signaling Peptides and Proteins
    Fibroblasts

    Keywords

    • Myofibroblast
    • Smooth muscle cell differentiation
    • TGF-β
    • TGFBR2 mutations
    • Thoracic aortic aneurysms and dissections

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Physiology (medical)
    • Physiology

    Cite this

    Inamoto, S., Kwartler, C. S., Lafont, A. L., Liang, Y. Y., Fadulu, V. T., Duraisamy, S., ... Milewicz, D. M. (2010). TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. Cardiovascular Research, 88(3), 520-529. https://doi.org/10.1093/cvr/cvq230

    TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. / Inamoto, Sakiko; Kwartler, Callie S.; Lafont, Andrea L.; Liang, Yao Yun; Fadulu, Van Tran; Duraisamy, Senthil; Willing, Marcia; Estrera, Anthony; Safi, Hazim; Hannibal, Mark C.; Carey, John; Wiktorowicz, John; Tan, Filemon K.; Feng, Xin Hua; Pannu, Hariyadarshi; Milewicz, Dianna M.

    In: Cardiovascular Research, Vol. 88, No. 3, 01.12.2010, p. 520-529.

    Research output: Contribution to journalArticle

    Inamoto, S, Kwartler, CS, Lafont, AL, Liang, YY, Fadulu, VT, Duraisamy, S, Willing, M, Estrera, A, Safi, H, Hannibal, MC, Carey, J, Wiktorowicz, J, Tan, FK, Feng, XH, Pannu, H & Milewicz, DM 2010, 'TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections', Cardiovascular Research, vol. 88, no. 3, pp. 520-529. https://doi.org/10.1093/cvr/cvq230
    Inamoto, Sakiko ; Kwartler, Callie S. ; Lafont, Andrea L. ; Liang, Yao Yun ; Fadulu, Van Tran ; Duraisamy, Senthil ; Willing, Marcia ; Estrera, Anthony ; Safi, Hazim ; Hannibal, Mark C. ; Carey, John ; Wiktorowicz, John ; Tan, Filemon K. ; Feng, Xin Hua ; Pannu, Hariyadarshi ; Milewicz, Dianna M. / TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. In: Cardiovascular Research. 2010 ; Vol. 88, No. 3. pp. 520-529.
    @article{de993b170e0e40cb994adb1ca501bffa,
    title = "TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections",
    abstract = "AimsTransforming growth factor-β (TGF-β) signaling is critical for the differentiation of smooth muscle cells (SMCs) into quiescent cells expressing a full repertoire of contractile proteins. Heterozygous mutations in TGF-β receptor type II (TGFBR2) disrupt TGF-β signaling and lead to genetic conditions that predispose to thoracic aortic aneurysms and dissections (TAADs). The aim of this study is to determine the molecular mechanism by which TGFBR2 mutations cause TAADs.Methods and resultsUsing aortic SMCs explanted from patients with TGFBR2 mutations, we show decreased expression of SMC contractile proteins compared with controls. Exposure to TGF-β1 fails to increase expression of contractile genes in mutant SMCs, whereas control cells further increase expression of these genes. Analysis of fixed and frozen aortas from patients with TGFBR2 mutations confirms decreased in vivo expression of contractile proteins relative to unaffected aortas. Fibroblasts explanted from patients with TGFBR2 mutations fail to transform into mature myofibroblasts with TGF-β1 stimulation as assessed by expression of contractile proteins.ConclusionsThese data support the conclusion that heterozygous TGFBR2 mutations lead to decreased expression of SMC contractile protein in both SMCs and myofibroblasts. The failure of TGFBR2-mutant SMCs to fully express SMC contractile proteins predicts defective contractile function in these cells and aligns with a hypothesis that defective SMC contractile function contributes to the pathogenesis of TAAD.",
    keywords = "Myofibroblast, Smooth muscle cell differentiation, TGF-β, TGFBR2 mutations, Thoracic aortic aneurysms and dissections",
    author = "Sakiko Inamoto and Kwartler, {Callie S.} and Lafont, {Andrea L.} and Liang, {Yao Yun} and Fadulu, {Van Tran} and Senthil Duraisamy and Marcia Willing and Anthony Estrera and Hazim Safi and Hannibal, {Mark C.} and John Carey and John Wiktorowicz and Tan, {Filemon K.} and Feng, {Xin Hua} and Hariyadarshi Pannu and Milewicz, {Dianna M.}",
    year = "2010",
    month = "12",
    day = "1",
    doi = "10.1093/cvr/cvq230",
    language = "English (US)",
    volume = "88",
    pages = "520--529",
    journal = "Cardiovascular Research",
    issn = "0008-6363",
    publisher = "Oxford University Press",
    number = "3",

    }

    TY - JOUR

    T1 - TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections

    AU - Inamoto, Sakiko

    AU - Kwartler, Callie S.

    AU - Lafont, Andrea L.

    AU - Liang, Yao Yun

    AU - Fadulu, Van Tran

    AU - Duraisamy, Senthil

    AU - Willing, Marcia

    AU - Estrera, Anthony

    AU - Safi, Hazim

    AU - Hannibal, Mark C.

    AU - Carey, John

    AU - Wiktorowicz, John

    AU - Tan, Filemon K.

    AU - Feng, Xin Hua

    AU - Pannu, Hariyadarshi

    AU - Milewicz, Dianna M.

    PY - 2010/12/1

    Y1 - 2010/12/1

    N2 - AimsTransforming growth factor-β (TGF-β) signaling is critical for the differentiation of smooth muscle cells (SMCs) into quiescent cells expressing a full repertoire of contractile proteins. Heterozygous mutations in TGF-β receptor type II (TGFBR2) disrupt TGF-β signaling and lead to genetic conditions that predispose to thoracic aortic aneurysms and dissections (TAADs). The aim of this study is to determine the molecular mechanism by which TGFBR2 mutations cause TAADs.Methods and resultsUsing aortic SMCs explanted from patients with TGFBR2 mutations, we show decreased expression of SMC contractile proteins compared with controls. Exposure to TGF-β1 fails to increase expression of contractile genes in mutant SMCs, whereas control cells further increase expression of these genes. Analysis of fixed and frozen aortas from patients with TGFBR2 mutations confirms decreased in vivo expression of contractile proteins relative to unaffected aortas. Fibroblasts explanted from patients with TGFBR2 mutations fail to transform into mature myofibroblasts with TGF-β1 stimulation as assessed by expression of contractile proteins.ConclusionsThese data support the conclusion that heterozygous TGFBR2 mutations lead to decreased expression of SMC contractile protein in both SMCs and myofibroblasts. The failure of TGFBR2-mutant SMCs to fully express SMC contractile proteins predicts defective contractile function in these cells and aligns with a hypothesis that defective SMC contractile function contributes to the pathogenesis of TAAD.

    AB - AimsTransforming growth factor-β (TGF-β) signaling is critical for the differentiation of smooth muscle cells (SMCs) into quiescent cells expressing a full repertoire of contractile proteins. Heterozygous mutations in TGF-β receptor type II (TGFBR2) disrupt TGF-β signaling and lead to genetic conditions that predispose to thoracic aortic aneurysms and dissections (TAADs). The aim of this study is to determine the molecular mechanism by which TGFBR2 mutations cause TAADs.Methods and resultsUsing aortic SMCs explanted from patients with TGFBR2 mutations, we show decreased expression of SMC contractile proteins compared with controls. Exposure to TGF-β1 fails to increase expression of contractile genes in mutant SMCs, whereas control cells further increase expression of these genes. Analysis of fixed and frozen aortas from patients with TGFBR2 mutations confirms decreased in vivo expression of contractile proteins relative to unaffected aortas. Fibroblasts explanted from patients with TGFBR2 mutations fail to transform into mature myofibroblasts with TGF-β1 stimulation as assessed by expression of contractile proteins.ConclusionsThese data support the conclusion that heterozygous TGFBR2 mutations lead to decreased expression of SMC contractile protein in both SMCs and myofibroblasts. The failure of TGFBR2-mutant SMCs to fully express SMC contractile proteins predicts defective contractile function in these cells and aligns with a hypothesis that defective SMC contractile function contributes to the pathogenesis of TAAD.

    KW - Myofibroblast

    KW - Smooth muscle cell differentiation

    KW - TGF-β

    KW - TGFBR2 mutations

    KW - Thoracic aortic aneurysms and dissections

    UR - http://www.scopus.com/inward/record.url?scp=78149350496&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=78149350496&partnerID=8YFLogxK

    U2 - 10.1093/cvr/cvq230

    DO - 10.1093/cvr/cvq230

    M3 - Article

    C2 - 20628007

    AN - SCOPUS:78149350496

    VL - 88

    SP - 520

    EP - 529

    JO - Cardiovascular Research

    JF - Cardiovascular Research

    SN - 0008-6363

    IS - 3

    ER -